Matrix metalloproteinse-9 expression in fetal membranes and maternal serum in cases of premature rupture of membranes: Impact of subclinical chorioamnionitis
Harras, H., Mohamed, E., Lotfy, H., Mohamed, D. (2021). Matrix metalloproteinse-9 expression in fetal membranes and maternal serum in cases of premature rupture of membranes: Impact of subclinical chorioamnionitis. EKB Journal Management System, 5(3), 59-67. doi: 10.21608/jcbr.2021.70155.1197
Heba Fouad Harras; Esraa Abd El aziz Mohamed; Hashem Adel Lotfy; Dareen Abd El aziz Mohamed. "Matrix metalloproteinse-9 expression in fetal membranes and maternal serum in cases of premature rupture of membranes: Impact of subclinical chorioamnionitis". EKB Journal Management System, 5, 3, 2021, 59-67. doi: 10.21608/jcbr.2021.70155.1197
Harras, H., Mohamed, E., Lotfy, H., Mohamed, D. (2021). 'Matrix metalloproteinse-9 expression in fetal membranes and maternal serum in cases of premature rupture of membranes: Impact of subclinical chorioamnionitis', EKB Journal Management System, 5(3), pp. 59-67. doi: 10.21608/jcbr.2021.70155.1197
Harras, H., Mohamed, E., Lotfy, H., Mohamed, D. Matrix metalloproteinse-9 expression in fetal membranes and maternal serum in cases of premature rupture of membranes: Impact of subclinical chorioamnionitis. EKB Journal Management System, 2021; 5(3): 59-67. doi: 10.21608/jcbr.2021.70155.1197

Matrix metalloproteinse-9 expression in fetal membranes and maternal serum in cases of premature rupture of membranes: Impact of subclinical chorioamnionitis

Egyptian Journal of Cancer and Biomedical Research
Article 6, Volume 5, Issue 3, September 2021, Page 59-67  XML PDF (13.57 MB)
Document Type: Original Article
DOI: 10.21608/jcbr.2021.70155.1197
View on SCiNiTO View on SCiNiTO
Authors
Heba Fouad Harras email orcid 1; Esraa Abd El aziz Mohamed2; Hashem Adel Lotfy3; Dareen Abd El aziz Mohamed4
1pathology department, faculty of medicine, Tanta university
2Department of Medical Microbiology and Immunology, Faculty of medicine, Tanta University, Egypt.
3Department of obstetrics and gynecology, Tanta University, Tanta, Egypt.
4pathology department , faculty of medicine , tanta univeristy , tanta , egypt
Abstract
Background: Matrix metalloproteinase-9 (MMP-9) is the most active MMPs in the fetomaternal membranes. It plays an important role in the breakdown and remodeling of these membranes. Thus, increased knowledge of its expression in cases of premature rupture of membranes (PROM) with and without chorioamnionitis (CA) is essential for developing effective treatment strategies. Patients and Methods: expression of MMP-9 in fetomaternal membranes and maternal serum were performed in 70 full-term pregnant women; 20 cases were with intact membranes (group I), 35 with PROM (group IIA) and 15 with PROM and CA (group IIB). Results: A significant difference in MMMP-9 expression was detected between the studied groups. The highest MMP-9 expression was reached in women with PROM accompanied by histological (subclinical) CA followed by women with PROM without CA, compared to the control group (with intact membranes) at the time of delivery. Immunohistochemical expression was associated with a concomitant increase in serum MMP-9. Conclusion: MMP-9 could predict women liable for premature rupture of membranes, and the determination of its serum level may be an effective tool for PROM detection.
Keywords
Chorioamnionitis; MMP-9; premature rupture of membrane
Statistics
Article View: 225
PDF Download: 231